US STOCK
BMY Stock Analysis
US stocks · market data · technical indicators
Bristol-Myers Squibb Co.
BMYUS stocksQuote delayed 15 min
10/26 下午05:34 updated
$61.48
-1.52-2.41%
Open
$62.66
High
$62.84
Low
$61.31
Volume
976.42萬
BMY price history
-3.76%Open
63.88
Latest
61.48
High
63.88
Low
56.67
Average
60.43
Advertisement
Financial snapshot
BMY - Bristol-Myers Squibb Company
EPS
4.54USD
Forward EPS
6.61USD
P/E
13.54x
Forward P/E
9.31x
P/B
5.63x
ROE
46.60%
ROA
10.72%
Operating margin
34.42%
Profit margin
18.87%
Revenue growth
5.70%
Earnings growth
153.10%
Dividend yield
4.10%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $12.97B | $11.49B | $12.50B | $12.22B | $12.27B |
| Gross profit | $9.25B | $8.07B | $8.41B | $8.79B | $8.90B |
| Operating income | $4.03B | $3.37B | $2.81B | $3.64B | $3.77B |
| Net income | $3.32B | $2.68B | $1.09B | $2.20B | $1.31B |
| Basic EPS | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 |
| Diluted EPS | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
1.25
Revenue estimate
$12.73B
Last surprise
+27.74%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | 1.25 | Not reported | — |
| 2026-07-30 | 1.60 | 2.04 | +27.74% |
| 2026-04-30 | 1.42 | 1.58 | +11.18% |
| 2026-02-05 | 1.20 | 1.26 | +4.57% |
| 2025-10-30 | 1.52 | 1.63 | +7.55% |
| 2025-07-31 | 1.10 | 1.46 | +32.60% |
| 2025-04-24 | 1.50 | 1.80 | +19.88% |
| 2025-02-06 | 1.47 | 1.67 | +13.80% |
| 2024-10-31 | 1.50 | 1.80 | +19.98% |
| 2024-07-26 | 1.63 | 2.07 | +27.37% |
| 2024-04-25 | -4.40 | -4.40 | -0.05% |
| 2024-02-02 | 1.58 | 1.70 | +7.77% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $10.7B | 0.16% |
| BlackRock Inc. | 2024-06-30 | $6.6B | 0.15% |
| STATE STREET CORP | 2026-06-30 | $5.9B | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $581.1M | 0.42% |
| CITADEL ADVISORS LLC | 2026-06-30 | $90.6M | 0.01% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$65.42
Target range
$41.00 – $82.00
Implied upside
6.40%
Strong buy
4
Buy
6
Hold
17
Sell
1
Strong sell
0
Dividends
Annual yield
3.07%
Frequency
Quarterly
Recent payouts
- 2026-07-02$0.6300
- 2026-04-02$0.6300
- 2026-01-02$0.6300
- 2025-10-03$0.6200
Advertisement